Last reviewed · How we verify
Placebo of TQH2722 injection — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of TQH2722 injection (Placebo of TQH2722 injection) — Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.. This is a placebo control with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of TQH2722 injection TARGET | Placebo of TQH2722 injection | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of TQH2722 injection CI watch — RSS
- Placebo of TQH2722 injection CI watch — Atom
- Placebo of TQH2722 injection CI watch — JSON
- Placebo of TQH2722 injection alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of TQH2722 injection — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-tqh2722-injection. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab